SWC’s Fast Five
Get a picture of new access to domestic-sourced pharmaceuticals, the anti-remote learning movement, a resizing of the office footprint, good news about a scary disease and then chill with the legacy of Bob Ross (psst, he permed his hair!).
So, here’s this week’s Fast Five:
1 Picture this: Kodak pivots to domestic drug production and it’s not as nutty as it sounds.
After declaring bankruptcy in 2012 after failing to capitalize on its invention of the digital camera, Kodak secures a government loan under the Defense Production Act to help expedite domestic production of drugs that can treat a variety of medical conditions and loosen the U.S. reliance on foreign sources.
2 Home schooling clusters, micro schools, learning pods emerge as families push back against remote learning.
So-called pandemic-proof learning labs are emerging as alternatives to remote learning as students prepare to return to whatever version of school is available to them this fall.
3 Who still needs the office? U.S. companies start cutting space.
It seems an obvious conclusion but early reporting had the work-from-home phenomena mitigated by businesses committed to the in-office experience opting for more square footage as they look to rethink the work-together experience in the coronavirus age.
4 A blood test for early detection of Alzheimers is at hand.
“The possibility of early detection and being able to intervene with a treatment before significant damage to the brain from Alzheimer’s disease would be game changing for individuals, families and our healthcare system.”
5 Bob Ross therapy. The fuzzy-haired painter is still the ultimate calming presence.
Twenty-five years after his death, Bob Ross Inc. is still thriving. What’s that about? The official Bob Ross YouTube channel, run by the company, has over 4 million subscribers and more than 360 million total views.